Press Releases from MEDraysintell (8 total)
Proton Therapy Industry, a first consolidation in a niche market
With the recent announcement of Hitachi to acquire the particle therapy business of Mitsubishi, we observe the first consolidation in the PT industry. Following this…
MEDraysintell downgrades its proton therapy market projection
In light of several factors summarized below, MEDraysintell is downgrading its proton therapy market projection from 1,200 proton therapy treatment rooms that were expected to…
Future and Economics of Nuclear Medicine
Need to understand future and economics of Nuclear Medicine? Looking for experts in this field? Trying to appreciate the potential of this new technology?
MEDraysintell will…
Impulse from radiotherapeutics confirms accelerated growth of nuclear medicine
MEDraysintell releases its new Nuclear Medicine World Market Report and Directory–Edition 2017, a 1,100-page document that provides an exhaustive description and analysis of more than…
MEDraysintell to showcase its reports at SNNMI in Denver
MEDraysintell will display its series of market reports and directories with over 1,900 pages of unrivaled intelligence covering Nuclear Medicine, Cyclotrons, Brachytherapy and Proton Therapy,…
Nuclear Medicine, Proton Therapy, Brachytherapy reports and directories
Nuclear medicine, proton therapy and brachytherapy are niche markets which together represents less than 0.1% of the global health expenditures but should grow three times…
MEDraysintell releases its Proton Therapy Market Essentials report 2017
MEDraysintell publishes its new “Proton Therapy Market Essentials” report providing key facts and figures on Proton Therapy to advice non-industry insiders on the potential for…
MEDraysintell releases its first Nuclear Medicine Market Essentials report
MEDraysintell publishes its new “Nuclear Medicine Market Essentials” report providing key facts and figures on Nuclear Medicine to advice non-industry insiders on the potential for…
Go To Page:
